Z-0528-2014 Class III Terminated
FDA device recall Z-0528-2014 was initiated by Remel Inc on Nov 21, 2012 and is designated Class III. Reason for recall: Boxes labeled as CIP5 may contain cartridges of AMP5. The recall status is terminated (terminated Mar 12, 2014). Affected quantity: 60/5/50-disc cartridge boxes.
Recall details
- Product Type
- Devices
- Report Date
- Dec 25, 2013
- Initiation Date
- Nov 21, 2012
- Termination Date
- Mar 12, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 60/5/50-disc cartridge boxes
Product description
Oxoid Antimicrobial Susceptibility Test Discs, CTO425B Ciprofloxacin CIP 5 mcg, 50 discs per cartridge, 5 cartridges per box. The firm name on the box label is Oxoid Ltd., Basingstoke, UK. Used in the semi-quantitative agar diffusion test method for in vitro susceptibility testing to assist in the determination of a suitable antibiotic agent for treatment purposes.
Reason for recall
Boxes labeled as CIP5 may contain cartridges of AMP5.
Distribution pattern
Nationwide Distribution including AL, CA, CO, FL, IA, KS, LA, MA, MS, NE, NH, NJ, NY, OK, OR, RI, TN, TX, VA, WA WI, and Puerto Rico.
Code information
Lot number: 1220205, exp July 21, 2015
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0528-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026